Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06351306
What this trial is testing

DEC-C and Thioguanine for R/R AML

Who this might be right for
Acute Myeloid Leukemia
Columbia University
Large-scale testing (Phase 3)Study completedNCT00005863
What this trial is testing

Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Medical Research Council
Testing effectiveness (Phase 2)Looking for participantsNCT06483906
What this trial is testing

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Early research (Phase 1)Ended earlyNCT03884829
What this trial is testing

A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS

Who this might be right for
AML, AdultMyelodysplastic SyndromesALL, Adult+2 more
Cyclacel Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT00002912
What this trial is testing

Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 3
Early research (Phase 1)Ended earlyNCT05038800
What this trial is testing

Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Chronic Myelomonocytic Leukemia
Merck Sharp & Dohme LLC 13
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Study completedNCT02395822
What this trial is testing

MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 17
Large-scale testing (Phase 3)Study completedNCT02668653
What this trial is testing

Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid LeukemiaLeukemia
Daiichi Sankyo 539
Large-scale testing (Phase 3)Ended earlyNCT02627677
What this trial is testing

A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Ariad Pharmaceuticals 44
Not applicableLooking for participantsNCT07254312
What this trial is testing

Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.

Who this might be right for
AML (Acute Myelogenous Leukemia
Fondazione IRCCS Policlinico San Matteo di Pavia 14
Testing effectiveness (Phase 2)WithdrawnNCT00967512
What this trial is testing

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Who this might be right for
Acute Myelogenous Leukemia
Eleos, Inc.
Not applicableStudy completedNCT07379528
What this trial is testing

Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome

Who this might be right for
Acute Myeloid Leukaemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 70
Testing effectiveness (Phase 2)Study completedNCT02581007
What this trial is testing

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+7 more
Northside Hospital, Inc. 25
Not applicableNo Longer AvailableNCT00413270
What this trial is testing

Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01061177
What this trial is testing

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Who this might be right for
CML in Chronic Phase
Novartis Pharmaceuticals 1,090
Testing effectiveness (Phase 2)Study completedNCT02113319
What this trial is testing

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
University Hospital, Angers 27
Not applicableEnded earlyNCT02276651
What this trial is testing

Observational Trial of a Therapeutic Platelet Transfusion Regimen

Who this might be right for
Acute Myeloid LeukemiaThrombocytopenia
Klinikum Nürnberg 25
Testing effectiveness (Phase 2)Looking for participantsNCT04047641
What this trial is testing

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more
M.D. Anderson Cancer Center 80
Not applicableLooking for participantsNCT07511829
What this trial is testing

WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment

Who this might be right for
MDS (Myelodysplastic Syndrome)AML (Acute Myeloid Leukemia)
University of Oxford 80
Next Page